1. United States Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Upper Street Marketing, Inc.

Upper Street Marketing, Inc.

OOTC:UPPR
0.00
USD
+0.00
(-99.00%)
-3.09EPS
257.69MMarket Cap
1999 Y
2000 Y
2001 Y
2002 Y
2003 Y
2004 Y
TTM
Revenue per Share
72.96
80.94
75.78
85.46
93.86
93.07
93.07
Basic EPS, GAAP
-1.9
-8.29
-5.9
4.34
-0.18
-3.09
-3.09
Free Cash Flow per Basic Share
-6.09
2.19
4.65
-1.57
4.32
3.71
3.71
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
23.13
21.63
15.74
20.07
19.89
16.8
16.8
Tangible Book Value per Share
23.13
21.63
15.74
20.07
19.89
16.8
16.8
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
6
7
6
7
8
8
8
Operating Margin (%)
0.16
-8.42
-1.51
8.67
1.11
-1.53
-1.53
Depreciation Expense
1
1
1
1
1
1
1
Net Income, GAAP
- -
-1
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-2.6
-10.24
-7.78
5.07
-0.2
-3.32
-3.32
Working Capital
- -
- -
- -
1
- -
1
1
LT Debt
4
4
3
4
4
4
4
Total Equity
2
2
1
2
2
1
1
Return on Invested Capital (%)
- -
- -
- -
10.03
- -
- -
- -
Return on Capital (%)
- -
- -
- -
5.87
- -
- -
- -
Return on Common Equity (%)
- -
-37.62
-31.56
24.22
-0.92
-16.84
-16.84

Capital Structure

USD

•

in mil. unless spec.
Jun'04
Sep'04
Dec'04
ST Debt
- -
- -
- -
LT Borrowings
4
4
4
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
- -
Market Capitalization
206
189
258

Working Capital

USD

•

in mil. unless spec.
Jun'04
Sep'04
Dec'04
Total Current Assets
2
3
2
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
1
1
1
Inventories
1
1
1
Total Current Liabilities
1
1
2
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-3.85%
-15.53%
Free Cash Flow
- -
-109.34%
-14.11%
Net Income, GAAP
- -
323.74%
1,574.15%
Sales/Revenue/Turnover
- -
6.06%
-0.84%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2002
3
2
1
1
7
2003
3
2
1
1
8
2004
3
2
1
1
8

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2002
6.45
3.6
-2.15
-3.56
4.34
2003
5.8
2.51
-5.56
-2.93
-0.18
2004
3.07
2.25
-1.37
-7.04
-3.09

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2002
- -
- -
- -
- -
- -
2003
- -
- -
- -
- -
- -
2004
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
John Quinn
Full Time Employees
3
Sector
Health technology
Industry
Pharmaceuticals: other
Address
11445 East Via Linda Lawndale AZ United States V6E 4A6
IPO Date
Dec 11, 1997
Website
upperstreetmarketing.com
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
Upper Street Marketing Inc. identifies and acquires distinct businesses demonstrating strong growth prospects. The company currently focuses its acquisition efforts on specialty and craft distilleries within the tequila and vodka markets, alongside innovative firms in the medical technology sector. It maintains its corporate presence in Scottsdale, Arizona.

Company News

Company News APIChatGPT

  • globenewswire.com

    Union Power Metals Advances Maiden Drill Program at Michalová Manganese Project, Slovakia

  • globenewswire.com

    Union Power Metals Confirms Upcoming Drill Program at Slovakia Manganese Projects